Vascular Access Technologies, Inc

Vascular Access Technologies has developed SAFECVAD, the world's first patented retrograde central venous access catheter. Every year in the US, there are more than 150,000 severe complications and 11,000 people die to to complications associated with central venous access. The market size is $1.5B and the affordable care act specifically lists the complications that SAFECVAD solves.